CVS Group (LON:CVSG) Stock Passes Above 200-Day Moving Average - Should You Sell?

Key Points

• CVS Group shares crossed above their 200-day moving average, reaching GBX 1,301 before last trading at GBX 1,297.44, up 0.6%.
• Analysts remain broadly positive, with four Buy ratings and one Hold rating producing a consensus “Moderate Buy” recommendation and an average price target of GBX 1,720.
• Insiders bought 3,860 shares worth approximately £4.96 million in the last quarter, while insiders own 1.48% of the company.

CVS Group plc (LON:CVSG - Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1,232.17 and traded as high as GBX 1,301. CVS Group shares last traded at GBX 1,297.44, with a volume of 1,635,865 shares traded.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and set a GBX 1,700 target price on shares of CVS Group in a report on Monday, July 27th. Berenberg Bank reissued a "buy" rating and set a GBX 2,000 price target on shares of CVS Group in a report on Thursday, July 23rd. Finally, Jefferies Financial Group raised their price target on shares of CVS Group from GBX 1,350 to GBX 1,400 and gave the company a "hold" rating in a research report on Friday, July 31st. Four analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat, CVS Group presently has a consensus rating of "Moderate Buy" and an average target price of GBX 1,720.

CVS Group Stock Up 0.6%

The company has a market cap of £881.87 million, a price-to-earnings ratio of 18.83, a PEG ratio of 1.77 and a beta of 1.07. The company has a current ratio of 1.07, a quick ratio of 0.90 and a debt-to-equity ratio of 92.34. The business has a fifty day moving average of GBX 1,281.19 and a two-hundred day moving average of GBX 1,232.17.

CVS Group announced that its board has approved a share buyback plan on Tuesday, May 26th that allows the company to repurchase 0 shares. This repurchase authorization allows the company to repurchase shares of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's board of directors believes its shares are undervalued.

Insider Activity

In related news, insider David Wilton acquired 1,500 shares of CVS Group stock in a transaction on Tuesday, August 4th. The stock was bought at an average cost of GBX 1,276 per share, for a total transaction of £19,140. Also, insider Joanne Shaw acquired 1,592 shares of CVS Group stock in a transaction on Monday, August 10th. The shares were bought at an average price of GBX 1,287 per share, with a total value of £20,489.04. Insiders have acquired 3,860 shares of company stock worth $4,956,696 in the last quarter. Corporate insiders own 1.48% of the company's stock.

About CVS Group

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy. The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct"). The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.